|
| 37645893 | Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections. | bioRxiv | 2024 |
| 37758193 | A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. | Neuro Oncol | 2024 |
| 37645893 | Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections. | bioRxiv | 2024 |
| 37758193 | A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. | Neuro Oncol | 2024 |
| 36264168 | N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. | Cancer Res | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36264168 | N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. | Cancer Res | 2023 |
| 37589977 | Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. | JAMA Netw Open | 2023 |
| 37655659 | Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors. | J Clin Invest | 2023 |
| 38079020 | "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 |
| 37138086 | Glioblastoma remodelling of human neural circuits decreases survival. | Nature | 2023 |
| 37016139 | Author Correction: Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression. | Nat Cell Biol | 2023 |
| 37104042 | Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. | J Clin Invest | 2023 |
| 36599113 | Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma. | J Clin Oncol | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 36723772 | Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. | Acta Neuropathol | 2023 |
| 38079020 | "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 |
| 37589977 | Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. | JAMA Netw Open | 2023 |
| 37655659 | Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors. | J Clin Invest | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 37016139 | Author Correction: Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression. | Nat Cell Biol | 2023 |
| 37104042 | Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. | J Clin Invest | 2023 |
| 37138086 | Glioblastoma remodelling of human neural circuits decreases survival. | Nature | 2023 |
| 36723772 | Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. | Acta Neuropathol | 2023 |
| 36599113 | Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma. | J Clin Oncol | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 34653254 | Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. | Neuro Oncol | 2022 |
| 35395677 | Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes. | Neuro Oncol | 2022 |
| 35703914 | Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma. | J Neuropathol Exp Neurol | 2022 |
| 35511927 | CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma. | Clin Cancer Res | 2022 |
| 35945463 | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Acta Neuropathol | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36130485 | GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer. | Cell Rep | 2022 |
| 35990705 | Prognostic risk stratification of gliomas using deep learning in digital pathology images. | Neurooncol Adv | 2022 |
| 35672531 | Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. | J Neurooncol | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36115057 | CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. | J Neurosurg | 2022 |
| 36114166 | Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer. | Nat Commun | 2022 |
| 35534562 | Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. | Nat Genet | 2022 |
| 36479058 | Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase. | Neurooncol Adv | 2022 |
| 36539501 | A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. | Nat Cancer | 2022 |
| 35063085 | Cellular architecture of human brain metastases. | Cell | 2022 |
| 34982879 | Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma. | Neurosurgery | 2022 |
| 34910220 | Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma. | Acta Neuropathol | 2022 |
| 35202840 | In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue. | Mol Cell Proteomics | 2022 |
| 34653254 | Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. | Neuro Oncol | 2022 |
| 34882581 | Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. | J Clin Invest | 2022 |
| 35287169 | PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications. | Neuro Oncol | 2022 |